2,8-Dibromodibenzothiophene

We are 2,8-Dibromodibenzothiophene CAS:31574-87-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2,8-Dibromodibenzothiophene
CAS.NO:31574-87-5
Synonyms:2,8-Dibromodibenzo[b,d]thiophene
2,8-Dibrom-dibenzothiophen
2,8-dibromo-dibenzothiophene
2,8-Dibromodibenzo[B,D]thiophene
Dibenzothiophene,2,8-dibromo
Molecular Formula:C12H6Br2S
Molecular Weight:342.04900
 
Physical and Chemical Properties:
Density:1.905
Melting point:226ºC
Boiling point:436.5ºC
Index of Refraction:1.785
 
Specification:
Appearance:White crystalline powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates

2,8-Dibromodibenzothiophene


Related News: With the structural upgrade of the pharmaceutical industry in developed countries, the transfer of related industrial chains has taken place globally, and it has also had a profound impact on Chinese pharmaceutical companies. near3,4-dimetoxifenetilamina CAS:120-20-7 “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said. Ácido (R, E) -5 – ([1,1'-bifenil] -4-il) -4 – ((terc-butoxicarbonil) amino) -2-metilpent-2-enoico CAS:1012341-48-8 Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.4-Chloro-7-methoxy-2-phenylquinoline Jo Soden, Co-managing Director of Retrogenix, said “We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant’s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.”Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the global pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules.

Related Products
Product Name
(2S)-Amino(3-hydroxyadamantan-1-yl)acetic acid View Details
Chloroiodomethane View Details
2′,4′-Dichlorovalerophenone View Details
6,7-Dimethoxyquinazoline-2,4-dione manufacturer 2-(4-Fluorophenyl)-5-[(5-iodo-2-Methylphenyl)methyl]thiophene manufacturer Dimethylthiophosphinoyl Chloride manufacturer Disperse Violet 57 Cas:61968-60-3 manufacturer meso-2,3-Dibromosuccinic acid manufacturer